The combination of common neuroosteoarthropathy and diabetic dermatopathy in type 2 diabetes mellitus

Alla Y. Tokmakova, Ekaterina S. Gracheva, Ekaterina L. Zaitseva, Alexandr V. Vorontsov

Research output: Contribution to journalArticlepeer-review

Abstract

Diabetic neuroosteoarthropathy (Charcot's osteoarthropathy, DNAP, Charcot's foot) is a common complication of diabetic neuropathy, which can be easily diagnosed in clinical practice and usually is corrected without leading to severe deformation of the affected joint in case of timely and adequate treatment. We present the result of long-term clinical observation of a patient with early development of complications of type 2 diabetes mellitus, diabetic dermatopathy, common DNOAP with damage to the joints of the feet, ankles, knees and elbows. A feature of the described clinical case is the prevalence of osteoarticular disorders with seizure of atypical diabetes zones - knee and elbow joints, the defeat of which is more characteristic of other diseases (such as collagenoses and syphilis), as well as a combination of DNOAP with diabetic dermatopathy. It seems that the causes of such a common arthropathic process lie in the long course of diabetic neuropathy, which debuted long before the diagnosis of type 2 diabetes, as well as the development and progression of this patient in the last decade of observing diabetic nephropathy and associated secondary hyperparathyroidism. In the modern literature, descriptions of combinations of dermatopathies with other complications of diabetes mellitus are extremely rare, and references to a combination of common DNAP and diabetic bullosis have not been found.

Original languageEnglish
Pages (from-to)201-208
Number of pages8
JournalDiabetes Mellitus
Volume23
Issue number2
DOIs
StatePublished - 2020
Externally publishedYes

Keywords

  • Charcot neuro-osteoarthropathy
  • Dermatopathy
  • Diabetes mellitus

Fingerprint

Dive into the research topics of 'The combination of common neuroosteoarthropathy and diabetic dermatopathy in type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this